With an initial investment of over 17 million euros for the development of 5,600 square meters of new laboratories dedicated to pharmaceutical technology and analytical chemistry, Alfasigma confirms its commitment to Research and Development. L’inauguration of ‘Labio 4.0 Marino Golinelli’, this morning in the Pomezia pharmaceutical group plant, is part of a broader corporate strategy of progressive investment in R&D, which allows Alfasigma, one of the top five pharmaceutical companies with Italian capital, to stand out both nationally and internationally for innovation and technological development.
Read Also
- Carlo Conti and the embarrassment of Vanessa Incontrada’s kiss Sep 4, 2021
- Sean Connery’s last public image Oct 31, 2020
- Educa renews business commitment in favor of education May 26, 2022
- Rai appointments: the postponement requested by the M5S suits everyone, especially Mario Draghi Jul 7, 2021
- Ilona Smet is celebrating its 25th anniversary : the tender message of his beloved Kamran May 17, 2020
- The dead miners rise to seven after an explosion in a mine in Colombia Jun 5, 2022
- The tiktoker Papi Kunno in controversy again: they confuse him with the protagonist of a sex video Oct 7, 2020